Impact of direct stenting on outcome of patients with ST-elevation myocardial infarction transferred for primary percutaneous coronary intervention (from the EUROTRANSFER registry)

Catheterization and Cardiovascular Interventions

Volumn 84, Issue 6, 2014, Pages 925-931

  Dziewierz, Artur ^a   Siudak, Zbigniew ^a   Rakowski, Tomasz ^a   Kleczyński, Pawel ^a   Zasada, Wojciech ^a   Dubiel, Jacek S ^a   Dudek, Dariusz ^a  

^a JAGIELLONIAN UNIVERSITY   (Poland)

Author keywords

Angioplasty; Direct stenting; Infarction; Predilatation; Registries; Stents

Indexed keywords

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CARDIOVASCULAR MORTALITY; CONTROLLED CLINICAL TRIAL (TOPIC); CORONARY STENTING; DIRECT STENTING; FEMALE; HUMAN; INTERMETHOD COMPARISON; LONG TERM SURVIVAL; MAJOR CLINICAL STUDY; MALE; NO REFLOW PHENOMENON; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; ST SEGMENT; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; ADVERSE EFFECTS; CHI SQUARE DISTRIBUTION; CLINICAL TRIAL; COMPARATIVE STUDY; DEVICES; EUROPE; KAPLAN MEIER METHOD; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; MYOCARDIAL INFARCTION; NO-REFLOW PHENOMENON; PROPENSITY SCORE; PROPORTIONAL HAZARDS MODEL; REGISTER; RISK; RISK FACTOR; STENT; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME;

AGED; ANGIOPLASTY, BALLOON, CORONARY; CHI-SQUARE DISTRIBUTION; CORONARY ANGIOGRAPHY; EUROPE; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; NO-REFLOW PHENOMENON; ODDS RATIO; PERCUTANEOUS CORONARY INTERVENTION; PROPENSITY SCORE; PROPORTIONAL HAZARDS MODELS; REGISTRIES; RISK FACTORS; STENTS; TREATMENT OUTCOME;

EID: 84930091046     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.25266     Document Type: Article

References (20)

1. De Luca G, Suryapranata H, Stone GW, Antoniucci D, Biondi- Zoccai G, Kastrati A, Chiariello M, Marino P. Coronary stenting versus balloon angioplasty for acute myocardial infarction: A meta-regression analysis of randomized trials. Int J Cardiol 2008;126:37-44.
2. Steg PG, James SK, Atar D, Badano LP, Blomstrom-Lundqvist C, Borger MA, di Mario C, Dickstein K, Ducrocq G, Fernandez-Aviles F, Gershlick AH, Giannuzzi P, Halvorsen S, Huber K, Juni P, Kastrati A, Knuuti J, Lenzen MJ, Mahaffey KW, Valgimigli M, van't Hof A, Widimsky P, Zahger D. ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J 2012;33:2569-2619.
3. Stone GW, Peterson MA, Lansky AJ, Dangas G, Mehran R, Leon MB. Impact of normalized myocardial perfusion after successful angioplasty in acute myocardial infarction. J Am Coll Cardiol 2002;39:591-597.
4. Henriques JP, Zijlstra F, van't Hof AW, de Boer MJ, Dambrink JH, Gosselink M, Hoorntje JC, Suryapranata H. Angiographic assessment of reperfusion in acute myocardial infarction by myocardial blush grade. Circulation 2003;107: 2115-2119.
5. Henriques JP, Zijlstra F, Ottervanger JP, de Boer MJ, van't Hof AW, Hoorntje JC, Suryapranata H. Incidence and clinical significance of distal embolization during primary angioplasty for acute myocardial infarction. Eur Heart J 2002;23:1112- 1117.
6. Dziewierz A, Dudek D. Advantages of MGuard coronary stent system. Minerva Cardioangiol 2012;60:33-40.
7. Dudek D, Mielecki W, Burzotta F, Gasior M, Witkowski A, Horvath IG, Legutko J, Ochala A, Rubartelli P, Wojdyla RM, Siudak Z, Buchta P, Pregowski J, Aradi D, Machnik A, Hawranek M, Rakowski T, Dziewierz A, Zmudka K. Thrombus aspiration followed by direct stenting: A novel strategy of primary percutaneous coronary intervention in ST-segment elevation myocardial infarction. Results of the Polish-Italian- Hungarian RAndomized ThrombEctomy Trial (PIHRATE Trial). Am Heart J 2010;160:966-972.
8. Dudek D, Dziewierz A, Rzeszutko L, Legutko J, Dobrowolski W, Rakowski T, Bartus S, Dragan J, Klecha A, Lansky AJ, Siudak Z, Zmudka K. Mesh covered stent in ST-segment elevation myocardial infarction. EuroIntervention 2010;6:582- 589.
9. Grygier M, Araszkiewicz A, Lesiak M, Grajek S. Role of adenosine as an adjunct therapy in the prevention and treatment of no-reflow phenomenon in acute myocardial infarction with ST segment elevation: Review of the current data. Kardiol Pol 2013;71:115-120.
10. Loubeyre C, Morice MC, Lefevre T, Piechaud JF, Louvard Y, Dumas P. A randomized comparison of direct stenting with conventional stent implantation in selected patients with acute myocardial infarction. J Am Coll Cardiol 2002;39:15-21.
11. Mockel M, Vollert J, Lansky AJ, Witzenbichler B, Guagliumi G, Peruga JZ, Brodie BR, Kornowski R, Dudek D, Farkouh ME, Parise H, Mehran R, Stone GW. Comparison of direct stenting with conventional stent implantation in acute myocardial infarction. Am J Cardiol 2011;108:1697-1703.
12. Dudek D, Siudak Z, Janzon M, Birkemeyer R, Aldama-Lopez G, Lettieri C, Janus B, Wisniewski A, Berti S, Olivari Z, Rakowski T, Partyka L, Goedicke J, Zmudka K. European registry on patients with ST-elevation myocardial infarction transferred for mechanical reperfusion with a special focus on early administration of abciximab-EUROTRANSFER Registry. Am Heart J 2008;156:1147-1154.
13. Siudak Z, Rakowski T, Dziewierz A, Janzon M, Birkemeyer R, Stefaniak J, Partyka L, Zmudka K, Dudek D. Early abciximab use in ST-elevation myocardial infarction treated with primary percutaneous coronary intervention improves long-term outcome. Data from EUROTRANSFER Registry. Kardiol Pol 2010;68:539-543.
14. Rakowski T, Siudak Z, Dziewierz A, Birkemeyer R, Legutko J, Mielecki W, Depukat R, Janzon M, Stefaniak J, Zmudka K, Dubiel JS, Partyka L, Dudek D. Early abciximab administration before transfer for primary percutaneous coronary interventions for ST-elevation myocardial infarction reduces 1-year mortality in patients with high-risk profile. Results from EUROTRANSFER registry. Am Heart J 2009;158:569- 575.
15. D'Agostino RB Jr. Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. Stat Med 1998;17:2265-2281.
16. Antoniucci D, Valenti R, Migliorini A, Moschi G, Bolognese L, Cerisano G, Buonamici P, Santoro GM. Direct infarct artery stenting without predilation and no-reflow in patients with acute myocardial infarction. Am Heart J 2001;142:684- 690.
17. Gasior M, Gierlotka M, Lekston A, Wilczek K, Zebik T, Hawranek M, Wojnar R, Szkodzinski J, Piegza J, Dyrbus K, Kalarus Z, Zembala M, Polonski L. Comparison of outcomes of direct stenting versus stenting after balloon predilation in patients with acute myocardial infarction (DIRAMI). Am J Cardiol 2007;100:798-805.
18. Rakowski T, Dudek D, Dziewierz A, Yu J, Witzenbichler B, Guagliumi G, Kornowski R, Hartmann F, Lansky AJ, Brener SJ, Mehran R, Stone GW. Impact of infarct-related artery patency before primary PCI on outcome in patients with ST-segment elevation myocardial infarction: The HORIZONS-AMI trial. EuroIntervention 2013;8:1307-1314.
19. Rakowski T, Siudak Z, Dziewierz A, Birkemeyer R, Janzon M, Mielecki W, Zmudka K, Dubiel JS, Dudek D. Impact of infarct related artery patency after early abciximab administration on one-year mortality in patients with ST-segment elevation myocardial infarction (data from the EUROTRANSFER Registry). Kardiol Pol 2012;70:215-221.
20. Svilaas T, Vlaar PJ, van der Horst I, Diercks GF, de Smet BJ, van den Heuvel AF, Anthonio RL, Jessurun GA, Tan ES, Suurmeijer AJ, Zijlstra F. Thrombus aspiration during primary percutaneous coronary intervention. N Engl J Med 2008;358:557-567.